ImmunoCellular Therapeutics, Ltd., a development stage company based in Woodland Hills, California. ImmunoCellular Therapeutics focuses on developing and commercializing therapeutics to treat cancer using the immune system. Its product candidate portfolio includes cellular immunotherapies targeting cancer and cancer stem cell antigens; peptide based immunotherapies targeting cancer stem cells; and... 

Delhi, India: For patients with severely dysfunctional organs, transplant becomes the last  option but finding a compatible donor to replace the organ is an uphill task. However, such patients won’t have to lose sleep looking for donors and compatibility, if biodegradable scaffolds, developed by Indian Institute of Technology Delhi (IITD), turn into a reality. In collaboration with AIIMS and... 

FDA Drug Approval The FDA hasn’t yet tallied its year-end drug approvals but will have the number by Friday. As of Dec. 1 the agency reported 25 new drugs approved.  In 2008 it approved 25 new drugs, that number is likely to go up by one when the final tally is taken. During 2009, the agency added 31 new or updated “black box” warning labels to drugs already on the market. That was... 

How to evaluate a Biotech Stock, especially small/startup Biotech stocks.  A fair evaluation is to be made before investing in any biotech stocks. If the drug gets FDA approval, chances are really good that the stock is going to go up. So, we’re looking for drugs that will likely get approval, but we’ll still have to confirm that the drug has the chance to make money. If it’s got no competitor,...